Free Delivery Over $100
|
|
|||
|
||||
Overview6 1/2 X 9 7/16 in 1. Overview (Satinder Ahuja). 2. HPLC Theory (Y.V. K azakevich). 3. HPLC Columns and Packings (U.D. Neue < EM>et al.). 4. Column Characterization and Select ion (D. Visky). 5. Chiral Separations (Xiande Wang et al.). 6. Contemporary Liquid Chromatographic Systems for Method Development (M. Swartz). 7. Hyphen ated Techniques (D.L. Norwood et al.). 8. HP LC Sample Preparation (G. Slack, N.H. Snow). 9. Instru ment and Software Qualification and Validation (D. Van Geel). 10. Pharmaceutical Development: From Pre-clinical to Post Appro val (K. Bynum). 11. HPLC Method Development for Drug D iscovery LC-MS Assays in Rapid PK Applications (Xiaoying Xu, W. Korfmach er). 12. HPLC Method Development in Early Phase Pharmac eutical Development (H.T. Rasmussen et al.). 1 3. HPLC Method Development in Late Phase Pharmaceutical Development (M. Ilias Jimidar). 14. Use of HPLC for In-process Testing Full Product DetailsAuthor: Satinder Ahuja (President, Ahuja Consulting for Water Quality, Calabash, NC, USA) , Henrik Rasmussen (Global Analytical Development, Johnson and Johnson Pharmaceutical Research and Development, Raritan, NJ, USA)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Edition: 8th edition Volume: v. 8 Dimensions: Width: 16.50cm , Height: 2.80cm , Length: 24.00cm Weight: 1.107kg ISBN: 9780123705402ISBN 10: 0123705401 Pages: 532 Publication Date: 15 May 2007 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Awaiting stock  The supplier is currently out of stock of this item. It will be ordered for you and placed on backorder. Once it does come back in stock, we will ship it out for you. Table of ContentsReviewsReview in Doody's 2008, by Joseph Boullata, PharmD(University of Pennsylvania College of Nursing): <br> This book is written with pharmaceutical scientists in mind, regardless of their level of experience with HPLC method development. By extension, it would be valuable for managers and regulators as well. It may also be of value to those managing a lab or research program in the academic setting. <br>The 18 chapters are written by 35 contributors, mostly from the U.S., with just over half from the pharmaceutical industry. The book is divided into two major sections, one a state-of-the-science review of HPLC and one on the unique needs in a pharmaceutical setting. This latter section is what makes the book most useful to the intended audience. It addresses topics such as method development for each phase in the drug development process, strategies for software/hardware validation, and prevention/troubleshooting problems. There is lots of concern for instrument qualification and validation in meeting regulatory requirements. The role of HPLC in tandem with mass spectrometry and other detection methods for assaying biological samples does not receive nearly as much attention. <br>Assessment: The book is clearly superior to the many books on HPLC methods development which do not address pharmaceutical issues to any great extent, if at all. There is generous use of figures and tables throughout and very little overlap across chapters. Weighted Numerical Score: 88 - 3 Stars Review in Doody's 2008, by Joseph Boullata, PharmD(University of Pennsylvania College of Nursing): <br> This book is written with pharmaceutical scientists in mind, regardless of their level of experience with HPLC method development. By extension, it would be valuable for managers and regulators as well. It may also be of value to those managing a lab or research program in the academic setting. <br>The 18 chapters are written by 35 contributors, mostly from the U.S., with just over half from the pharmaceutical industry. The book is divided into two major sections, one a state-of-the-science review of HPLC and one on the unique needs in a pharmaceutical setting. This latter section is what makes the book most useful to the intended audience. It addresses topics such as method development for each phase in the drug development process, strategies for software/hardware validation, and prevention/troubleshooting problems. There is lots of concern for instrument qualification andy Author InformationSatinder Ahuja obtained his Ph.D. in analytical chemistry from the Philadelphia College of Pharmacy and Science. He serves as adjunct research professor at Pace University and is a consultant to pharmaceutical companies as president of Ahuja Consulting. Tab Content 6Author Website:Countries AvailableAll regions |
||||
